Endoscopy Center, Prince of Wales Hospital
Hong Kong (sar), China
NCT Number: NCT00280332
* To determine the prevalence of colonic neoplasm in patients who had previously undergone screening colonoscopy * To determine the optimal time interval for re-screening in average risk individuals * To determine potential baseline characteristics that predicts adenoma recurrence
Looking for future studies?
Notify Me50 year–75 year
All sexes
Observational
Hong Kong (sar), China
Colorectal cancer (CRC) is the second commonest cancer in Hong Kong, and tends to be increasing. Screening for colorectal cancer can reduce the cancer incidence and mortality by detecting early lesions. However, the best interval for a follow up colonoscopy, particularly for those with normal baseline colonoscopy, remains largely unknown.
This study aim to determine the prevalence of colonic neoplasm in average-risk patients who had previously undergone screening colonoscopy and the optimal time interval for re-screening.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
proform a follow up colonoscopy in the 5 year period from index colonoscopy
Other names: follow up colonoscopy
Time frame: 5 year from index colonoscopy
Time frame: 5 years from index colonoscopy
Chinese University of Hong Kong
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00600496
Breast Cancer, Breast Diseases
Detroit, Michigan, United States
View Trial DetailsNCT03446157
Cancer of the Colon, Colon Cancer
Chapel Hill, North Carolina, United States
View Trial DetailsNCT06134089
Colonic Cancer, Colonic Diseases
Salt Lake City, Utah, United States
View Trial DetailsNCT04906343
Colonic Cancer, Colonic Diseases
Móstoles, Madrid, Spain
View Trial Details